|
Q3 FY2022
As of Dec 31, 2021
|
Q2 FY2022
As of Sep 30, 2021
|
Q1 FY2022
As of Jun 30, 2021
|
Q4 FY2021
As of Mar 31, 2021
|
Q3 FY2021
As of Dec 31, 2020
|
Q2 FY2021
As of Sep 30, 2020
|
Q1 FY2021
As of Jun 30, 2020
|
Q4 FY2020
As of Mar 31, 2020
|
Q3 FY2020
As of Dec 31, 2019
|
Q2 FY2020
As of Sep 30, 2019
|
Q1 FY2020
As of Jun 30, 2019
|
Q4 FY2019
As of May 15, 2019
|
Q3 FY2019
As of Dec 31, 2018
|
Q2 FY2019
As of Sep 30, 2018
|
Q1 FY2019
As of Jun 30, 2018
|
Q4 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Mar 31, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Current assets | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Short-term investments | ||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||
| Deferred contract costs, net | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Deferred contract costs, net of current portion | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities and shareholders' equity | ||||||||||||||||||
| Current liabilities | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||
| Deferred revenue | ||||||||||||||||||
| Current portion of finance lease obligations | ||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Deferred revenue, net of current portion | ||||||||||||||||||
| Long-term finance lease obligations | ||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||
| Long-term debt | ||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Shareholders' equity | ||||||||||||||||||
| Ordinary shares, $0.012 par value, 300,000,000 shares authorized; 66,907,431 and 64,562,222 shares issued and outstanding as of December 31, 2021 and March 31, 2021, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||
Loading...
